Search results for: Market Access

Just Published: Testing the Feasibility of Obtaining EQ-5D-5L Values in the United Arab Emirates

23 October 2015

…feasibility and cultural appropriateness of stated preference methods to generate health state values in the United Arab Emirates. Value in Health Regional Issues, 7C, pp.34-41. Access the paper here. Click…

Eliciting the Relative Value of Life Extension at the End of Life

29 November 2016

…and an expensive death? Exploring societal perspectives. BMC Medical Ethics, 16(14). [access here free-of-charge] Access Rachel’s slides below. Perspective, priorities and plurality from Office of Health Economics Following Rachel’s presentation,…

Does a Biomedical Research Centre Affect Patient Care in Local Hospitals?

20 February 2017

…was undertaken by OHE’s Grace Marsden in collaboration with colleagues from RAND Europe and Oxford BRC. The study was commissioned by Oxford BRC. Access the full article [open access] here….

Around the World in HTAs: Canada – Autonomous yet Collaborative

9 April 2025

…HTA processes, including time-limited recommendations to facilitate timely patient access to promising treatments. A common criticism of CDA-AMC’s assessment processes is that it limits access to new treatments and may…

OHE at HTAi 2017: Meet the Team

13 June 2017

…methods. Presentation: Access to Orphan Drugs in the UK and Other European Countries OHE Authors: Bernarda Zamora, Martina Garau, Francois Maignen, Phill O’Neill Time & Date: Tuesday 20th June, 18:00…

Approaches, Challenges and Successful Stories of Multi-indication Pricing in Europe

28 November 2018

…thus opening treatment access to more patients, and will stimulate future research, because manufacturers can recoup R&D costs more easily. Despite the theoretical attractiveness of MIP, health care system stakeholders…

OHE at the 2019 Spanish Health Economics Association (AES) Conference

5 June 2019

…of innovative medicines: the case of risperidone and second-generation antipsychotics This study, co-authored by Mikel Berdud, Bernarda Zamora, and Adrian Towse, aims to guide access decisions and drive the discussion…

Value, Affordability, and Decision Making

…and financial reforms outlined in Vision 2030. These changes are creating a dynamic environment for health technologies and their pathway to market. Read more 9 June 2025 Around the world…

Augmenting Cost-Effectiveness Analysis for Uncertainty: The Implications for Value Assessment—Rationale and Empirical Support

14 April 2020

…Manufacturers of America (PhRMA). The full article has been published as an open access licence and can be accessed on the Journal of Managed Care & Specialty Pharmacy website here….